Stock Information

• Which dow jones stocks are moving on Friday?
  Fri, May 29, 2026 7:10 PM
• RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) demonstrates prolonged clinical benefit as a first-line treatment for atypical EGFR-mutated non-small cell lung cancer
  Fri, May 29, 2026 6:00 PM
• Explore the top gainers and losers within the dow jones index in today's session.
  Fri, May 29, 2026 4:40 PM
• VYM Climbs 26% In a Year While Its Core Dividend Payers Extend Their Streaks
  Fri, May 29, 2026 2:01 PM
• AbbVie Stock: Is ABBV Outperforming the Healthcare Sector?
  Fri, May 29, 2026 1:33 PM
• Want $1,400 in Passive Income? Invest $10,000 Into These 4 Dividend Stocks
  Fri, May 29, 2026 12:30 PM
• New TECVAYLI®▼ (teclistamab) data demonstrate superior progression-free and overall survival versus standard of care as early as first relapse in multiple myeloma
  Fri, May 29, 2026 12:24 PM
• New TECVAYLI® (teclistamab-cqyv) data demonstrate superior progression-free and overall survival as early as first relapse in multiple myeloma
  Fri, May 29, 2026 12:17 PM
• Johnson & Johnson Announces New Data From Its Phase 3 MajesTEC-9 Study That Show Clinically Meaningful And Statistically Significant Survival Improvements With TECVAYLI In Patients With Relapsed Or Refractory Multiple Myeloma
  Fri, May 29, 2026 8:21 AM
• J&J CEO Joaquin Duato: It's our mission to become the number 1 company in oncology by 2030
  Fri, May 29, 2026 8:10 AM

Financial data not available